Austin father loses vision after taking Wegovy; questions raised about rare condition
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Austin father loses vision after taking Wegovy; questions raised about rare condition" is generating significant coverage in the Health category, with 9 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include MindBodyGreen, American Academy of Ophthalmology, Newswise and Medscape. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 39d ago.
Quick answers
Why is "Austin father loses vision after taking Wegovy; questions raised about rare cond" trending?
Because 7 independent news sources published 9 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (9)
- Taking GLP-1s Was Linked To 18% Lower Risk Of This Eye Condition MindBodyGreen · 42d ago
- GLP-1 Drugs Linked to Faster Vision Loss in the Second Eye, New Study Finds American Academy of Ophthalmology · 42d ago
- For People With Diabetes, GLP-1 Drugs May Be Linked to Lower Odds of a Leading Cause of Blindness Newswise · 42d ago
- GLP-1 Drugs Linked to Faster Vision Loss in the Second Eye, New Study Finds Newswise · 42d ago
- For People With Diabetes, GLP-1 Drugs May Be Linked to Lower Odds of a Leading Cause of Blindness American Academy of Ophthalmology · 42d ago
- GLP-1s and NAION: Do Patients Need a Warning? Medscape · 42d ago
- GLP-1s changed weight loss. Why hundreds of lawsuits now flood NJ Bergen Record · 42d ago
- Doctor warns GLP-1 users about rare vision risk that may be permanent 95.5 WSB · 42d ago
- Austin father loses vision after taking Wegovy; questions raised about rare condition KXAN Austin · 42d ago
Topics
Related trends
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Novo Nordisk reports Wegovy injection reduced BMI and obesity rates in children as young as six in a clinical trial, expanding the drug's potential pediatric use.
The GLP-1 boom has a dark side
FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.
DJ Khaled reflects on using GLP-1s in 90-pound weight loss journey: ‘I needed help’
DJ Khaled publicly details a 75-to-90-pound weight loss aided by GLP-1 medication Wegovy, sparking wide entertainment-media coverage.
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Internal medicine physician Dr. Frank Dumont warns that stopping GLP-1 medications like Ozempic and Zepbound carries six rebound risks, including rapid weight regain, loss of cardiovascular protection, and worsening mental health.
Austin businesses brace for federal hemp ban, look to new state leadership
A looming federal hemp ban threatens to upend a multi-billion dollar industry, forcing Austin businesses and national brands like Crescent Canna to brace for layoffs and closures while pinning hopes on new state leadership.
KATSEYE’s Megan Performs While Sitting Due to Concussion, Sparking Fan Concern: ‘Are They Serious?’
KATSEYE member Megan performed seated in sunglasses at an Austin concert while recovering from a concussion, prompting fan backlash over her return to the stage.